{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:38:50Z","timestamp":1792031930421,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71329-y","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:02:16Z","timestamp":1725526936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolomic profiling identifies novel metabolites associated with cardiac dysfunction"],"prefix":"10.1038","volume":"14","author":[{"given":"Kasen L.","family":"Culler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Filipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Giro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norrina B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"10","key":"71329_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay, S. M., Roger, V. L. & Redfield, M. M. Epidemiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 14(10), 591\u2013602. https:\/\/doi.org\/10.1038\/nrcardio.2017.65 (2017).","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"71329_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah, S. J. et al. Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group Summary. Circulation. 141(12), 1001\u20131026. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041886 (2020).","journal-title":"Circulation."},{"issue":"3","key":"71329_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s44161-022-00032-w","volume":"1","author":"GG Schiattarella","year":"2022","unstructured":"Schiattarella, G. G. et al. Immunometabolic mechanisms of heart failure with preserved ejection fraction. Nat. Cardiovasc. Res. 1(3), 211\u2013222. https:\/\/doi.org\/10.1038\/s44161-022-00032-w (2022).","journal-title":"Nat. Cardiovasc. Res."},{"issue":"12","key":"71329_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D. & McLean, J. A. Untargeted metabolomics strategies-challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27(12), 1897\u20131905. https:\/\/doi.org\/10.1007\/s13361-016-1469-y (2016).","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"4","key":"71329_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/aje\/kwt004","volume":"178","author":"Y Zheng","year":"2013","unstructured":"Zheng, Y. et al. Associations between metabolomic compounds and incident heart failure among African Americans: The ARIC Study. Am. J. Epidemiol. 178(4), 534\u2013542. https:\/\/doi.org\/10.1093\/aje\/kwt004 (2013).","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"71329_CR6","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1002\/ehf2.12923","volume":"7","author":"C Andersson","year":"2020","unstructured":"Andersson, C. et al. Metabolomic signatures of cardiac remodelling and heart failure risk in the community. ESC Heart Failure. 7(6), 3707\u20133715. https:\/\/doi.org\/10.1002\/ehf2.12923 (2020).","journal-title":"ESC Heart Failure."},{"issue":"1","key":"71329_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007275","volume":"14","author":"UA Tahir","year":"2021","unstructured":"Tahir, U. A. et al. Metabolomic profiles and heart failure risk in black adults: Insights from the Jackson Heart Study. Circ. Heart Fail. 14(1), e007275. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007275 (2021).","journal-title":"Circ. Heart Fail."},{"key":"71329_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003190","author":"WG Hunter","year":"2016","unstructured":"Hunter, W. G. et al. Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: Evidence for shared metabolic impairments in clinical heart failure. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.115.003190 (2016).","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"71329_CR9","doi-asserted-by":"publisher","first-page":"e015118","DOI":"10.1161\/JAHA.119.015118","volume":"9","author":"AC Razavi","year":"2020","unstructured":"Razavi, A. C. et al. Novel findings from a metabolomics study of left ventricular diastolic function: The Bogalusa Heart Study. J. Am. Heart Assoc. 9(3), e015118. https:\/\/doi.org\/10.1161\/JAHA.119.015118 (2020).","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"71329_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/circheartfailure.112.968701","volume":"5","author":"EY Choi","year":"2012","unstructured":"Choi, E. Y. et al. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ. Heart Fail. 5(6), 727\u2013734. https:\/\/doi.org\/10.1161\/circheartfailure.112.968701 (2012).","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"71329_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/circheartfailure.111.964841","volume":"5","author":"SK Agarwal","year":"2012","unstructured":"Agarwal, S. K. et al. Prediction of incident heart failure in general practice: The Atherosclerosis Risk in Communities (ARIC) Study. Circ. Heart Fail. 5(4), 422\u2013429. https:\/\/doi.org\/10.1161\/circheartfailure.111.964841 (2012).","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"71329_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jamacardio.2021.0131","volume":"6","author":"AM Reimer Jensen","year":"2021","unstructured":"Reimer Jensen, A. M. et al. Association of left ventricular systolic function with incident heart failure in late life. JAMA Cardiol. 6(5), 509\u2013520. https:\/\/doi.org\/10.1001\/jamacardio.2021.0131 (2021).","journal-title":"JAMA Cardiol."},{"issue":"6","key":"71329_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","volume":"29","author":"G de Simone","year":"2008","unstructured":"de Simone, G., Gottdiener, J. S., Chinali, M. & Maurer, M. S. Left ventricular mass predicts heart failure not related to previous myocardial infarction: The Cardiovascular Health Study. Eur. Heart J. 29(6), 741\u2013747. https:\/\/doi.org\/10.1093\/eurheartj\/ehm605 (2008).","journal-title":"Eur. Heart J."},{"issue":"9","key":"71329_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild, D. E. et al. Multi-ethnic study of atherosclerosis: Objectives and design. Am. J. Epidemiol. 156(9), 871\u2013881. https:\/\/doi.org\/10.1093\/aje\/kwf113 (2002).","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"71329_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker, L. A. et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367(1), 20\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1114248 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"71329_CR16","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1021\/ac5025039","volume":"86","author":"AC Dona","year":"2014","unstructured":"Dona, A. C. et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal. Chem. 86(19), 9887\u20139894. https:\/\/doi.org\/10.1021\/ac5025039 (2014).","journal-title":"Anal. Chem."},{"issue":"10","key":"71329_CR17","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/atvbaha.122.318222","volume":"43","author":"WG Hunter","year":"2023","unstructured":"Hunter, W. G. et al. Metabolomic profiling of cholesterol efflux capacity in a multiethnic population: Insights from MESA. Arterioscler. Thromb. Vasc. Biol. 43(10), 2030\u20132041. https:\/\/doi.org\/10.1161\/atvbaha.122.318222 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"71329_CR18","doi-asserted-by":"publisher","first-page":"e010810","DOI":"10.1161\/jaha.118.010810","volume":"8","author":"IJ Neeland","year":"2019","unstructured":"Neeland, I. J. et al. Metabolomics profiling of visceral adipose tissue: Results from MESA and the NEO study. J. Am. Heart Assoc. 8(9), e010810. https:\/\/doi.org\/10.1161\/jaha.118.010810 (2019).","journal-title":"J. Am. Heart Assoc."},{"issue":"34","key":"71329_CR19","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1093\/eurheartj\/ehz235","volume":"40","author":"I Tzoulaki","year":"2019","unstructured":"Tzoulaki, I. et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur. Heart J. 40(34), 2883\u20132896. https:\/\/doi.org\/10.1093\/eurheartj\/ehz235 (2019).","journal-title":"Eur. Heart J."},{"issue":"1","key":"71329_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 28(1), 1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"21","key":"71329_CR21","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/circulationaha.120.045810","volume":"142","author":"S Sanders-van Wijk","year":"2020","unstructured":"Sanders-van Wijk, S. et al. Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: Results from the PROMIS-HFpEF study. Circulation. 142(21), 2029\u20132044. https:\/\/doi.org\/10.1161\/circulationaha.120.045810 (2020).","journal-title":"Circulation."},{"issue":"3","key":"71329_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81(3), 559\u2013575. https:\/\/doi.org\/10.1086\/519795 (2007).","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"71329_CR23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.cardfail.2023.02.003","volume":"29","author":"P Giro","year":"2023","unstructured":"Giro, P. et al. Missense genetic variation of ICAM1 and incident heart failure. J. Card. Fail. 29(8), 1163\u20131172. https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.003 (2023).","journal-title":"J. Card. Fail."},{"issue":"D1","key":"71329_CR24","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47(D1), D1005\u2013D1012 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"7762","key":"71329_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","volume":"570","author":"GL Wojcik","year":"2019","unstructured":"Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature. 570(7762), 514\u2013518. https:\/\/doi.org\/10.1038\/s41586-019-1310-4 (2019).","journal-title":"Nature."},{"issue":"6","key":"71329_CR26","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1002\/ehf2.12923","volume":"7","author":"C Andersson","year":"2020","unstructured":"Andersson, C. et al. Metabolomic signatures of cardiac remodelling and heart failure risk in the community. ESC Heart Fail. 7(6), 3707\u20133715. https:\/\/doi.org\/10.1002\/ehf2.12923 (2020).","journal-title":"ESC Heart Fail."},{"issue":"10","key":"71329_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/circresaha.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128(10), 1487\u20131513. https:\/\/doi.org\/10.1161\/circresaha.121.318241 (2021).","journal-title":"Circ. Res."},{"issue":"5","key":"71329_CR28","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.26355\/eurrev_202103_25279","volume":"25","author":"AK Kiani","year":"2021","unstructured":"Kiani, A. K. et al. From Myo-inositol to D-chiro-inositol molecular pathways. Eur. Rev. Med. Pharmacol. Sci. 25(5), 2390\u20132402. https:\/\/doi.org\/10.26355\/eurrev_202103_25279 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"71329_CR29","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","volume":"95","author":"ML Croze","year":"2013","unstructured":"Croze, M. L. & Soulage, C. O. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 95(10), 1811\u20131827. https:\/\/doi.org\/10.1016\/j.biochi.2013.05.011 (2013).","journal-title":"Biochimie."},{"issue":"5","key":"71329_CR30","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/anie.201502227","volume":"55","author":"MP Thomas","year":"2016","unstructured":"Thomas, M. P., Mills, S. J. & Potter, B. V. The \u201cother\u201d inositols and their phosphates: Synthesis, biology, and medicine (with recent advances in myo-inositol chemistry). Angew. Chem. Int. Ed. Engl. 55(5), 1614\u20131650. https:\/\/doi.org\/10.1002\/anie.201502227 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"71329_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1373\/clinchem.2016.257279","volume":"63","author":"M Mueller-Hennessen","year":"2017","unstructured":"Mueller-Hennessen, M. et al. A novel lipid biomarker panel for the detection of heart failure with reduced ejection fraction. Clin. Chem. 63(1), 267\u2013277. https:\/\/doi.org\/10.1373\/clinchem.2016.257279 (2017).","journal-title":"Clin. Chem."},{"issue":"1","key":"71329_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-015-0661-3","volume":"13","author":"M Deidda","year":"2015","unstructured":"Deidda, M. et al. Metabolomic approach to profile functional and metabolic changes in heart failure. J. Transl. Med. 13(1), 297. https:\/\/doi.org\/10.1186\/s12967-015-0661-3 (2015).","journal-title":"J. Transl. Med."},{"issue":"5","key":"71329_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2362.2010.02441.x","volume":"41","author":"D Alexander","year":"2011","unstructured":"Alexander, D., Lombardi, R., Rodriguez, G., Mitchell, M. M. & Marian, A. J. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur. J. Clin. Investig. 41(5), 527\u2013538. https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02441.x (2011).","journal-title":"Eur. J. Clin. Investig."},{"key":"71329_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lfs.2019.01.040","volume":"221","author":"MD McKirnan","year":"2019","unstructured":"McKirnan, M. D. et al. Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction. Life Sci. 221, 212\u2013223. https:\/\/doi.org\/10.1016\/j.lfs.2019.01.040 (2019).","journal-title":"Life Sci."},{"key":"71329_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910575","author":"S Dinicola","year":"2021","unstructured":"Dinicola, S. et al. Inositols: From established knowledge to novel approaches. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms221910575 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"71329_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-001989","author":"JJ DiNicolantonio","year":"2022","unstructured":"DiNicolantonio, J. J. & Okeefe, J. H. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open Heart. https:\/\/doi.org\/10.1136\/openhrt-2022-001989 (2022).","journal-title":"Open Heart."},{"issue":"1","key":"71329_CR37","doi-asserted-by":"publisher","first-page":"19889","DOI":"10.1038\/s41598-019-56496-7","volume":"9","author":"F Al-Khelaifi","year":"2019","unstructured":"Al-Khelaifi, F. et al. Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance. Sci. Rep. 9(1), 19889. https:\/\/doi.org\/10.1038\/s41598-019-56496-7 (2019).","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"71329_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1023\/a:1007142919941","volume":"213","author":"W El-Aroussy","year":"2000","unstructured":"El-Aroussy, W. et al. Plasma carnitine levels as a marker of impaired left ventricular functions. Mol. Cell Biochem. 213(1\u20132), 37\u201341. https:\/\/doi.org\/10.1023\/a:1007142919941 (2000).","journal-title":"Mol. Cell Biochem."},{"issue":"5","key":"71329_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124844","volume":"10","author":"BN Zordoky","year":"2015","unstructured":"Zordoky, B. N. et al. Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS ONE. 10(5), e0124844. https:\/\/doi.org\/10.1371\/journal.pone.0124844 (2015).","journal-title":"PLoS ONE."},{"key":"71329_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24183251","author":"M Almannai","year":"2019","unstructured":"Almannai, M., Alfadhel, M. & El-Hattab, A. W. Carnitine inborn errors of metabolism. Molecules. https:\/\/doi.org\/10.3390\/molecules24183251 (2019).","journal-title":"Molecules."},{"issue":"15","key":"71329_CR41","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/circulationaha.122.061846","volume":"147","author":"VS Hahn","year":"2023","unstructured":"Hahn, V. S. et al. Myocardial metabolomics of human heart failure with preserved ejection fraction. Circulation. 147(15), 1147\u20131161. https:\/\/doi.org\/10.1161\/circulationaha.122.061846 (2023).","journal-title":"Circulation."},{"issue":"2","key":"71329_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.trsl.2012.10.006","volume":"161","author":"SM Marcovina","year":"2013","unstructured":"Marcovina, S. M. et al. Translating the basic knowledge of mitochondrial functions to metabolic therapy: Role of l-carnitine. Transl. Res. 161(2), 73\u201384. https:\/\/doi.org\/10.1016\/j.trsl.2012.10.006 (2013).","journal-title":"Transl. Res."},{"issue":"1","key":"71329_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/2047487318797395","volume":"26","author":"ZY Zhang","year":"2019","unstructured":"Zhang, Z. Y. et al. Diastolic left ventricular function in relation to circulating metabolic biomarkers in a population study. Eur. J. Prev. Cardiol. 26(1), 22\u201332. https:\/\/doi.org\/10.1177\/2047487318797395 (2019).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"4","key":"71329_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown, D. A. et al. Mitochondrial function as a therapeutic target in heart failure. Nat. Rev. Cardiol. 14(4), 238\u2013250 (2017).","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"71329_CR45","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/S0021-9258(17)30124-2","volume":"254","author":"LJ Reitzer","year":"1979","unstructured":"Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254(8), 2669\u20132676 (1979).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"71329_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.119.006336","volume":"12","author":"PJ Kennel","year":"2019","unstructured":"Kennel, P. J. et al. Impairment of myocardial glutamine homeostasis induced by suppression of the amino acid carrier SLC1A5 in failing myocardium. Circ. Heart Fail. 12(12), e006336. https:\/\/doi.org\/10.1161\/circheartfailure.119.006336 (2019).","journal-title":"Circ. Heart Fail."},{"issue":"12","key":"71329_CR47","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1021\/pr500629t","volume":"13","author":"X He","year":"2014","unstructured":"He, X. & Slupsky, C. M. Metabolic fingerprint of dimethyl sulfone (DMSO2) in microbial-mammalian co-metabolism. J. Proteome Res. 13(12), 5281\u20135292. https:\/\/doi.org\/10.1021\/pr500629t (2014).","journal-title":"J. Proteome Res."},{"issue":"5","key":"71329_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/nbm.966","volume":"18","author":"UFH Engelke","year":"2005","unstructured":"Engelke, U. F. H. et al. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional 1H and two-dimensional 1H\u201313C NMR. NMR Biomed. 18(5), 331\u2013336. https:\/\/doi.org\/10.1002\/nbm.966 (2005).","journal-title":"NMR Biomed."},{"issue":"10","key":"71329_CR49","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/circulationaha.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques, F. Z. et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 135(10), 964\u2013977. https:\/\/doi.org\/10.1161\/circulationaha.116.024545 (2017).","journal-title":"Circulation."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71329-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:02:36Z","timestamp":1725526956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71329"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71329-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.S. has received research grants from AstraZeneca, Corvia, and Pfizer, and consulting fees from Abbott, Alleviant, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer-Ingelheim, Boston Scientific, Bristol Myers Squibb, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Imara, Impulse Dynamics, Intellia, Ionis, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sardocor, Shifamed, Tenax, Tenaya, and Ultromics. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20694"}}